Ariel Isser

Ariel Isser

Johns Hopkins University

H-index: 7

North America-United States

About Ariel Isser

Ariel Isser, With an exceptional h-index of 7 and a recent h-index of 7 (since 2020), a distinguished researcher at Johns Hopkins University, specializes in the field of Immunoengineering, Cancer Immunotherapy, Nanotechnology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Particle elasticity influences polymeric artificial antigen presenting cell effectiveness in vivo via CD8+ T cell activation, macrophage uptake, and the protein corona

1215 Using nanoparticles as artificial antigen presenting cells to activate human CD4 T cells for immunotherapy

Adaptive nanoparticle platforms for high throughput expansion and detection of antigen-specific t cells

Using nanoparticles as artificial antigen presenting cells to mobilize CD4 T cells for immunotherapy.

Shape matters: Biodegradable anisotropic nanoparticle artificial antigen presenting cells for cancer immunotherapy

Nanoparticle-based modulation of CD4+ T cell effector and helper functions enhances adoptive immunotherapy

Cross-reactivity of SARS-CoV-2–and influenza A–specific T cells in individuals exposed to SARS-CoV-2

TARGETING CD4 T CELLS WITH NANOTECHNOLOGY FOR ENHANCED CANCER IMMUNOTHERAPY

Ariel Isser Information

University

Position

___

Citations(all)

269

Citations(since 2020)

259

Cited By

53

hIndex(all)

7

hIndex(since 2020)

7

i10Index(all)

7

i10Index(since 2020)

7

Email

University Profile Page

Google Scholar

Ariel Isser Skills & Research Interests

Immunoengineering

Cancer Immunotherapy

Nanotechnology

Top articles of Ariel Isser

Particle elasticity influences polymeric artificial antigen presenting cell effectiveness in vivo via CD8+ T cell activation, macrophage uptake, and the protein corona

Nano Research

2024/4/4

Ariel Isser
Ariel Isser

H-Index: 4

Elana Ben-Akiva
Elana Ben-Akiva

H-Index: 6

1215 Using nanoparticles as artificial antigen presenting cells to activate human CD4 T cells for immunotherapy

2023/11/1

Ariel Isser
Ariel Isser

H-Index: 4

Adaptive nanoparticle platforms for high throughput expansion and detection of antigen-specific t cells

2020/6/28

Using nanoparticles as artificial antigen presenting cells to mobilize CD4 T cells for immunotherapy.

The Journal of Immunology

2023/5/1

Ariel Isser
Ariel Isser

H-Index: 4

Shape matters: Biodegradable anisotropic nanoparticle artificial antigen presenting cells for cancer immunotherapy

Acta Biomaterialia

2023/4/1

Elana Ben-Akiva
Elana Ben-Akiva

H-Index: 6

Ariel Isser
Ariel Isser

H-Index: 4

Nanoparticle-based modulation of CD4+ T cell effector and helper functions enhances adoptive immunotherapy

Nature communications

2022/10/14

Cross-reactivity of SARS-CoV-2–and influenza A–specific T cells in individuals exposed to SARS-CoV-2

JCI insight

2022/9/9

TARGETING CD4 T CELLS WITH NANOTECHNOLOGY FOR ENHANCED CANCER IMMUNOTHERAPY

2022/5/2

Biodegradable cationic polymer blends for fabrication of enhanced artificial antigen presenting cells to treat melanoma

ACS applied materials & interfaces

2021/2/12

Ariel Isser
Ariel Isser

H-Index: 4

Elana Ben-Akiva
Elana Ben-Akiva

H-Index: 6

Biomaterials to enhance antigen-specific T cell expansion for cancer immunotherapy

2021/1/1

Rapid expansion of highly functional antigen-specific T cells from patients with melanoma by nanoscale artificial antigen-presenting cells

Clinical Cancer Research

2020/7/1

Commensal bacteria stimulate antitumor responses via T cell cross-reactivity

JCI insight

2020/4/4

See List of Professors in Ariel Isser University(Johns Hopkins University)